← Back to Search

Dietary Supplement

Trulacta breastmilk supplement for Aging

Phase 2
Recruiting
Research Sponsored by TruDiagnostic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up testing will compare results from baseline to completion of 3 months of the supplement
Awards & highlights

Study Summary

This trial will test if the Trulacta supplement has any effect on biological age, sleep quality, immune system, and wellness markers.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~testing will compare results from baseline to completion of 3 months of the supplement
This trial's timeline: 3 weeks for screening, Varies for treatment, and testing will compare results from baseline to completion of 3 months of the supplement for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Epigenetic Age
Secondary outcome measures
Sleep Quality

Trial Design

1Treatment groups
Experimental Treatment
Group I: Trulacta breastmilk supplementExperimental Treatment1 Intervention
Once daily Trulacta supplement

Find a Location

Who is running the clinical trial?

Adventa BiosciencesUNKNOWN
TruDiagnosticLead Sponsor
11 Previous Clinical Trials
456 Total Patients Enrolled
8 Trials studying Aging
346 Patients Enrolled for Aging
~9 spots leftby Jun 2025